Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report

被引:0
作者
de Assis, Tabata Carolina Faria Nascimento [1 ]
Rapatoni, Liane [2 ]
Segato, Flavio Nogueira [2 ]
Pontes, Barbhara Thais Maciel [1 ]
Muglia, Valdair Francisco [3 ]
Neto, Miguel Moyses [1 ]
Romao, Elen Almeida [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Div Nephrol, 3900 Ave Bandeirantes, BR-14048900 Ribeirao Preto, SP, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Med Imaging Haematol & Clin Oncol, Div Clin Oncol, BR-14048900 Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Med Imaging Hematol & Clin Oncol, Div Med Imaging, BR-14048900 Ribeirao Preto, SP, Brazil
关键词
renal cell carcinoma; collecting duct carcinoma; kidney transplant; chemotherapy; dialysis; case report; disease-free survival; CISPLATIN CHEMOTHERAPY; GEMCITABINE; PATIENT; GUIDELINES; METABOLITE;
D O I
10.3892/ol.2024.14661
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Collecting duct carcinoma (CDC) is a rare disease associated with a high mortality rate. The present study describes the case of a recipient of a kidney transplant with metastatic allograft CDC whose treatment was successful. The patient underwent nephrectomy, and chemotherapy with gemcitabine and cisplatin, while undergoing haemodialysis treatment and remained in remission after 6 years of follow-up. There is a lack of information about the treatment and clinical management of CDC; however, the combination of gemcitabine and cisplatin remains as first-line therapy. The challenge of this case was integrating chemotherapy sessions with dialysis therapy to maintain the effectiveness, tolerability and safety of the oncological treatment. In the present case report, the success of chemotherapy with gemcitabine and cisplatin was demonstrated in a metastatic renal allograft CDC in a patient with end-stage renal disease, with few side effects and no recurrence of the disease 6 years after the end of treatment.
引用
收藏
页数:5
相关论文
共 19 条
[1]   p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system [J].
Carvalho, Jason C. ;
Thomas, Dafydd G. ;
McHugh, Jonathan B. ;
Shah, Rajal B. ;
Kunju, Lakshmi P. .
HISTOPATHOLOGY, 2012, 60 (04) :597-608
[2]  
Chang PY, 2013, J BUON, V18, P1058
[3]   The KDIGO Clinical Practice Guidelines for the Care of Kidney Transplant Recipients [J].
Chapman, Jeremy R. .
TRANSPLANTATION, 2010, 89 (06) :644-645
[4]   A Case of Gemcitabine and Cisplatin Chemotherapy in a Patient With Metastatic Urothelial Carcinoma Receiving Hemodialysis [J].
Ezaki, Taisuke ;
Matsumoto, Kazuhiro ;
Morita, Shinya ;
Shinoda, Kazunobu ;
Mizuno, Ryuichi ;
Kikuchi, Eiji ;
Oya, Mototsugu .
CLINICAL GENITOURINARY CANCER, 2016, 14 (04) :E413-E416
[5]   Guidelines for treatment of renal injury during cancer chemotherapy 2016 [J].
Horie, Shigeo ;
Oya, Mototsugu ;
Nangaku, Masaomi ;
Yasuda, Yoshinari ;
Komatsu, Yasuhiro ;
Yanagita, Motoko ;
Kitagawa, Yuko ;
Kuwano, Hiroyuki ;
Nishiyama, Hiroyuki ;
Ishioka, Chikashi ;
Takaishi, Hiromasa ;
Shimodaira, Hideki ;
Mogi, Akira ;
Ando, Yuichi ;
Matsumoto, Koji ;
Kadowaki, Daisuke ;
Muto, Satoru .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (01) :210-244
[6]   Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients [J].
Janus, N. ;
Thariat, J. ;
Boulanger, H. ;
Deray, G. ;
Launay-Vacher, V. .
ANNALS OF ONCOLOGY, 2010, 21 (07) :1395-1403
[7]   Pharmacokinetics of gemcitabine in a patient with end-stage renal disease:: effective clearance of its main metabolite by standard hemodialysis treatment [J].
Kiani, A ;
Köhne, CH ;
Franz, T ;
Passauer, J ;
Haufe, T ;
Gross, P ;
Ehninger, G ;
Schleyer, E .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) :266-270
[8]   Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer [J].
Masumori, Naoya ;
Kunishima, Yasuharu ;
Hirobe, Megumi ;
Takeuchi, Motoi ;
Takayanagi, Akio ;
Tsukamoto, Taiji ;
Itoh, Tatsuya .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (03) :182-185
[9]   Management of Metastatic Collecting Duct Carcinoma: An Encouraging Result in a Patient Treated With Cabozantinib [J].
Mennitto, Alessia ;
Verzoni, Elena ;
Peverelli, Giorgia ;
Alessi, Alessandra ;
Procopio, Giuseppe .
CLINICAL GENITOURINARY CANCER, 2018, 16 (03) :E521-E523
[10]   Renal collecting (bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma [J].
Orsola, A ;
Trias, I ;
Raventos, CX ;
Español, I ;
Cecchini, L ;
Orsola, I .
UROLOGY, 2005, 65 (01) :49-54